Thiogenesis Therapeutics (TSXV:TTI) Accumulated other comprehensive income (loss) : C$1.62 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Thiogenesis Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Thiogenesis Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was C$1.62 Mil.

Thiogenesis Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (C$1.64 Mil) to Dec. 2024 (C$1.57 Mil) but then increased from Dec. 2024 (C$1.57 Mil) to Mar. 2025 (C$1.62 Mil).

Thiogenesis Therapeutics's annual Accumulated other comprehensive income (loss) increased from Feb. 2022 (C$0.00 Mil) to Dec. 2023 (C$1.66 Mil) but then declined from Dec. 2023 (C$1.66 Mil) to Dec. 2024 (C$1.57 Mil).

Thiogenesis Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Thiogenesis Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thiogenesis Therapeutics Accumulated other comprehensive income (loss) Chart

Thiogenesis Therapeutics Annual Data

Trend

Dec19

Dec20

Feb21

Feb22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.03

1.66

1.57

Thiogenesis Therapeutics Quarterly Data
	Dec19	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial													1.54	1.60	1.64	1.57	1.62

Thiogenesis Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Thiogenesis Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Thiogenesis Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Thiogenesis Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thiogenesis Therapeutics Corp (TSXV:TTI) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

TTIPF:USA Q8M:Germany

Address

4 King Street West, Suite 401, Toronto, ON, CAN, M5H 1B6

Website

https://www.thiogenesis.com

Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic compounds, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the Company's compound, was developed to address the obstacles facing previous thiol-based drugs, their short half-live, and side effects and it's initial applications are for mitochondrial disease, Rett syndrome, and pediatric NASH.

Executives